In silico repurposing of clinically approved drugs as potential BRAF inhibitors: a pharmacophore-based virtual screening and experimental investigation. [PDF]
Amini H +6 more
europepmc +1 more source
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors. [PDF]
Gallego-Yerga L +7 more
europepmc +1 more source
Pharmacophore-based virtual screening, molecular docking, MD simulation, MM-GBSA energy calculation and DFT analysis for the <i>in silico</i> discovery of a SaFtsZ inhibitor. [PDF]
T S +5 more
europepmc +1 more source
Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Plasmodium falciparum with Favourable ADME Profiles. [PDF]
Bieri C +7 more
europepmc +1 more source
Development of potential CDK9 inhibitors through pharmacophore-based virtual screening, 3D-QSAR, molecular docking, MD simulation, and in vitro anticancer evaluation. [PDF]
Reddyrajula R +8 more
europepmc +1 more source
Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies. [PDF]
Yazdani M +4 more
europepmc +1 more source
Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease. [PDF]
El-Ashrey MK +4 more
europepmc +1 more source
Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction <i>via</i> pharmacophore-based virtual screening, molecular dynamics simulations and <i>in vitro/vivo</i> evaluation. [PDF]
Wu W +5 more
europepmc +1 more source
Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase. [PDF]
Gotina L +4 more
europepmc +1 more source

